Creative Planning’s Vor Biopharma VOR Stock Holding History

Creative Planning’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$221K	Buy	+11,586	New	+$247K	﹤0.01%	3894

Other funds holding VOR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Creative Planning's VOR Position: Q3 2026 in Review

Creative Planning opened a new position in Vor Biopharma (VOR) in Q3 2026: 11,586 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3894 among its holdings.

47 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

Creative Planning held 11,586 shares of Vor Biopharma worth $221K as of Q3 2026.
Vor Biopharma was a new Creative Planning position in Q3 2026.
Vor Biopharma made up ﹤0.01% of Creative Planning's portfolio in Q3 2026, its #3894 holding.
47 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.